Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Tony Loughman"'
Autor:
Verena Kainz, Christian F. Singer, Florian Fitzal, Margaretha Rudas, Martin Filipits, Peter Regitnig, Michael Gnant, Zsuzsanna Bago-Horvath, Stephen Barron, Richard Greil, Marija Balic, Dominik Hlauschek, William M. Gallagher, Tony Loughman, Des O'Leary, Stefan Halper, Wolfgang Hulla, Peter Dubsky, Daniel Egle
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 27(21)
Purpose: To validate the clinical performance of the OncoMasTR Risk Score in the biomarker cohort of Austrian Breast and Colorectal Cancer Study Group (ABCSG) Trial 8. Experimental Design: We evaluated the OncoMasTR test in 1,200 formalin-fixed, para
Autor:
Cecily Quinn, Aurelie Fabre, Karin Jirström, Desmond O'Leary, Tony Loughman, Adrian P. Bracken, C-Ja Wang, Peter Dynoodt, C Lopez-Ruiz, S. Stapleton, William M. Gallagher, Bozena Fender, Björn Nodin, Stephen Barron
Publikováno v:
Cancer Research. 79:P4-08
This abstract was withdrawn by the authors. Citation Format: Loughman T, Wang C-JA, Dynoodt P, Fender B, Lopez-Ruiz C, Barron S, Stapleton S, O'Leary D, Fabre A, Quinn C, Nodin B, Jirström K, Bracken A, Gallagher WM. Withdrawn [abstract]. In: Procee
Autor:
Chan-Ju A. Wang, Anthony O'Grady, Nebras Al-Attar, John Crown, Seodhna M. Lynch, Joanna Fay, Fiona Lanigan, Tony Loughman, Peter Dynoodt, Katherine M. Sheehan, Darran P. O'Connor, William M. Gallagher, Bozena Fender, Desmond O'Leary, Catherine M. Kelly, Adrian P. Bracken, Arman Rahman, Stephen Barron, Rut Klinger, Niamh Russell, Verena Amberger-Murphy, Claudia Aura Gonzalez, Anurati Saha, Cesar Lopez-Ruiz
Publikováno v:
European journal of cancer (Oxford, England : 1990). 152
The aim of the study was to assess the prognostic performance of a 6-gene molecular score (OncoMasTR Molecular Score [OMm]) and a composite risk score (OncoMasTR Risk Score [OM]) and to conduct a within-patient comparison against four routinely used
Autor:
Chan-Ju Angel Wang, Jack Cuzick, Peter Dynoodt, Stephen Barron, Richard Buus, Ivana Sestak, Bozena Fender, Cesar Lopez Ruiz, Des O'Leary, William M. Gallagher, Tony Loughman, Mitch Dowsett
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 26(3)
Purpose: To test the validity of OncoMasTR Molecular Score (OMm), OMclin1, and OncoMasTR Risk Score (OMclin2) prognostic scores for prediction of distant recurrence (DR) in estrogen receptor (ER)-positive/HER2-negative breast cancer treated with 5 ye
Autor:
Anthony O'Grady, Peter Dynoodt, Catherine M. Kelly, William M. Gallagher, Tony Loughman, Bozena Fender, Darran P. O'Connor, Arman Rahman, Nebras Al Attar, Seodhna M. Lynch, Katherine M. Sheehan, Niamh Russell, Claudia Aura Gonzalez, Anurati Saha, Chan-Ju Angel Wang, Joanna Fay, John Crown, Stephen Barron, Desmond O'Leary, Adrian P. Bracken
Publikováno v:
Journal of Clinical Oncology. 37:535-535
535 Background: Multigene prognostic signatures (MGPS) can identify early stage breast cancer patients who may require less aggressive treatment. To be clinically useful, MGPSs must provide additional prognostic information to clinicopathological inf
Autor:
Cecily Quinn, Karin Jirström, Aurelie Fabre, Desmond O'Leary, Björn Nodin, Adrian P. Bracken, Tony Loughman, William M. Gallagher, C. Lopez Ruiz, Bozena Fender, Stephen Barron, Peter Dynoodt, A. Chan-Ju Wang, S. Stapleton
Publikováno v:
Annals of Oncology. 29:viii65
Background: OncoMasTR is a new multigene prognostic test that was discovered via a novel transcriptional network analysis method that identified upstream Master Transcription Regulators (MTRs), which regulate previously identified prognostic biomarke
Autor:
Seodhna M. Lynch, Verena Amberger-Murphy, Joanna Fay, Katherine M. Sheehan, Niamh Russell, Anthony O'Grady, Stephen Barron, Darran P. O'Connor, Catherine M. Kelly, Bozena Fender, John Crown, Anurati Saha, Chan-Ju Angel Wang, Tony Loughman, Desmond O'Leary, Peter Dynoodt, Cesar Lopez Ruiz, William M. Gallagher
Publikováno v:
Journal of Clinical Oncology. 36:12074-12074
12074Background: Multigene prognostic signatures (MGPS) enable identification of early stage breast cancer (BC) patients requiring less aggressive treatment. OncoMasTR is a new MGPS found via a nov...
Autor:
Richard Buus, Cesar Lopez Ruiz, Desmond O'Leary, Tony Loughman, Ivana Sestak, Chan-Ju Angel Wang, Jack Cuzick, William M. Gallagher, Peter Dynoodt, Bozena Fender, Mitchell Dowsett, Stephen Barron
Publikováno v:
Journal of Clinical Oncology. 36:553-553
553Background: The assessment of distant recurrence (DR) risk in patients with early estrogen receptor (ER) positive breast cancer receiving adjuvant endocrine therapy is essential in making decisi...
Autor:
Helena Jernström, Bozena Fender, Tony Loughman, Christian Ingvar, W. M. Gallagher, Björn Nodin, Peter Dynoodt, B. Moran, Karin Jirström, C Lopez-Ruiz, C-J.A. Wang, Stephen Barron
Publikováno v:
Annals of Oncology. 28:v62
Autor:
Daniel Gordin, Valma Harjutsalo, Johan Wadén, Per-Henrik Groop, Nina Tolonen, Tony Loughman, Merlin C. Thomas, Carol Forsblom, Lena M. Thorn, John Moran, Markku Saraheimo
Publikováno v:
Diabetes care. 37(8)
OBJECTIVE Recent studies have suggested that circulating levels of the tumor necrosis factor-α receptor 1 (sTNFαR1) may be a useful predictor for the risk of end-stage renal disease (ESRD) in patients with diabetes. However, its potential utility a